Strainsforpains announces substantial increase in revenues for 2023
The original release is unavailable here.
Earlier from E-Buy Home
- Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.
- Strainsforpains, Inc. Investors Update: Strainsforpains, Inc. Showing Strong Revenue Growth
- Strainsforpains Interviewe with Stock Day Podcast
- Strainsforpains Inc. Announces Corporate Update
- Strainsforpains, Inc. secures its largest orders to date from NYC establishments
Later from E-Buy Home
- Strainsforpains-EBYH, CEO Simon Shainberg Signs Strategic Product Commercialization Agreement with Cannabis Science; Shainberg’s 2024 Guidance Projects Strong Revenue Growth For Its Multiplied Cannabinoid Drug Commercialization Pipeline
- Strainsforpains (OTC: EBYH) Formally Announces Alliance with the 1-Million Strong Killing Cancers, Fight Club (1MSFC) and the Inaugural Live 1MSFC #1 MMA Fight for 4th Quarter 2024 in Florida! Appoints Former WWE, TV Executive VP, Mr. Steven A. Smith Jr.,
- Strainsforpains (OTC: EBYH) Formally Announces Alliance with the 1-Million Strong Killing Cancers, Fight Club
- Strainsforpains, Inc. collaborates with major hospitals
- Strainsforpains EBYH (OTC: EBYH), Collaborates with Mt. Sinai Hospital in New York City and Johns Hopkins in Baltimore to Merge Advanced AI Data Integrations and Interactions Into Its Proprietary Healthcare APP for Instant Multiple Indications and Critica
Follow E-Buy Home into a list and get an email when it puts out news.
Follow E-Buy Home